
The Engineering Biology for Advanced Therapeutics Hub is a multi-institutional academic research initiative led by the University of Edinburgh, in collaboration with the University of Oxford, Imperial College London and the Cancer Research UK Scotland Institute.
Harnessing engineering biology, the Hub develops genetic control systems to underpin the next generation of safe, efficient and cost-effective advanced therapies, enabling precise control at the right location, level and time.